WALTHAM, Mass., March 26, 2026 – Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative,...
WALTHAM, Mass., March 20, 2026 – Sironax, a global clinical-stage biotechnology company developing transformative therapies for...
...
WALTHAM, Mass., Nov. 6, 2025 – Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative...
WALTHAM, Mass., Oct. 22, 2025 – Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative...
WALTHAM, Mass., Sept. 19, 2025 – Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative...
...
WALTHAM, Mass, July 9, 2025 – Sironax, a clinical-stage biotech company dedicated to the discovery and development of transformational therapies...
Following significant progress in its R&D pipeline, Sironax is embarking on a new phase of global expansion, focusing on the clinical development...